GlassScriptPhysician profile
Matthew Christopher Mcgee
NPI 1861740862
$1,155.49
in general payments reported to CMS, 2019-2025
16 companies · $153 in 2025
The $153 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.20 · 2020: $42.97 · 2021: $180 · 2022: $136 · 2023: $302 · 2024: $253 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $370.23 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $185.43 | 2019-2025 | |
| Corium, LLC | $144.36 | 2021-2023 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $87.27 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $75.09 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $56.14 | 2022-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $47.56 | 2022-2023 | M-M-R II, Vaxelis, Gardasil 9 |
| Adlon Therapeutics L.P. | $37.22 | 2020-2021 | |
| Sanofi Pasteur INC. | $33.18 | 2022-2024 | |
| Tris Pharma INC | $20.35 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.46 | 2023 | Flumist Quadrivalent |
| Supernus Pharmaceuticals, INC. | $16.84 | 2022 | |
| Phadia US INC. | $16.38 | 2021 | |
| Organon LLC | $16.29 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $16.15 | 2025 | Neffy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $14.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.